In Boston, a contractual rupture between two of the region's most prominent health institutions has left cancer patients — among the most vulnerable in any healthcare system — without access to the specialized care they had come to depend on. Mass General Brigham Health Plan's removal of Dana-Farber Cancer Institute from its Medicare Advantage network is not merely an administrative realignment; it is a reminder that when large institutions negotiate, individual patients often bear the cost of disagreement. The episode surfaces a deeper tension embedded in the Medicare Advantage model itself:
Cancer patients caught in crossfire as MGB Health removes Dana-Farber from Medicare Advantage
Cancer patients lose access to Dana-Farber Cancer Institute, disrupting ongoing treatment and forcing beneficiaries to seek alternative providers or face care gaps.
Health & Medicine